Fiasp (Insulin Aspart (Vials)) and Inotuzumab ozogamicin Intravenous
Determining the interaction of Fiasp (Insulin Aspart (Vials)) and Inotuzumab ozogamicin Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: inotuzumab ozogamicin
Brand name: Besponsa
Synonyms: Inotuzumab ozogamicin, Inotuzumab Ozogamicin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Fiasp (Insulin Aspart (Vials))-Inova
- Fiasp (Insulin Aspart (Vials))-Inova 4/1 topical
- Fiasp (Insulin Aspart (Vials))-Inova 8/2 topical
- Fiasp (Insulin Aspart (Vials))-Inova ACT
- Fiasp (Insulin Aspart (Vials))-Inrebic
- Fiasp (Insulin Aspart (Vials))-Inspra
- Inotuzumab ozogamicin Intravenous-Fiasp FlexTouch
- Inotuzumab ozogamicin Intravenous-Fiasp Injection
- Inotuzumab ozogamicin Intravenous-Fiber Lax
- Inotuzumab ozogamicin Intravenous-Fiber Laxative
- Inotuzumab ozogamicin Intravenous-FiberCon
- Inotuzumab ozogamicin Intravenous-FiberGen